Yan Jin

Yan Jin

Auto-generated profile, based on publicly available information

Yan Jin

Division of Healthcare Technology Assessment Research, National Evidence-based Healthcare Collaborating Agency, Seoul, South Korea

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
1 January 2021 in Infection & Chemotherapy
Verified
Journal Article
Open access
PDF file
SKSun Bean Kim
Sun Bean Kim
SRSeungeun Ryoo
Seungeun Ryoo
KHKyungmin Huh
Kyungmin Huh
EJEun-Jeong Joo
Eun-Jeong Joo
YKYoun Jeong Kim
Youn Jeong Kim
K(Korean Society Of Infectious Diseases (Ksid)
Korean Society Of Infectious Diseases (Ksid)
Kim SB, et al. Infect Chemother. 2021 Mar;53(1):166-219. https://doi.org/10.3947/ic.2021.0303

1 January 2022 in Investigative and Clinical Urology
Verified
Journal Article
Open access
PDF file
YJYan Jin
Yan Jin
JJJae Hung Jung
Jae Hung Jung
WHWoong Kyu Han
Woong Kyu Han
EHEu Chang Hwang
Eu Chang Hwang
YNYoonmi Nho
Yoonmi Nho
SYSu-Yeon Yu
Su-Yeon Yu
Jin Y, et al. Investig Clin Urol. 2022 May;63(3):251-261. https://doi.org/10.4111/icu.20210429

11 December 2023 in BMC Health Services Research
Verified
Journal Article
Open access
PDF file
HLHyeon-Jeong Lee
Hyeon-Jeong Lee
SCSonghee Cho
Songhee Cho
JPJungeun Park
Jungeun Park
YJYan Jin
Yan Jin
HKHyungMin Kim
HyungMin Kim
DJDonghyun Jee
Donghyun Jee
Background: We determined the cost-effectiveness of the anti-vascular endothelial growth factor (VEGF) intravitreal injection versus panretinal photocoagulation (PRP) for patients with proliferative diabetic retinopathy (PDR) in South Korea. Methods: We simulated four treatment strategies using PRP and the anti-VEGF injection by constructing a Markov model for a hypothetical cohort of 50-year-old PDR patients: (1) PRP only; (2) anti-VEGF injection only; (3) PRP first; and (4) anti-VEGF injection first. Results: In this cost-effectiveness analysis, compared with only-PRP, the incremental cost-effectiveness ratio was $95,456 per quality-adjusted life-year (QALY) for PRP first, $34,375 per QALY for anti-VEGF injection first, and $33,405 per QALY for anti-VEGF injection only from a healthcare perspective. From the societal and payer perspective, strategy (2) was more cost-saving and effective than (1). In the probabilistic sensitivity analysis, only-PRP was cost-effective up to the willingness-to-pay (WTP) of about $42,000, while anti-VEGF injection only was cost-effective from a healthcare perspective. From the societal and payer perspectives, regardless of the value of WTP, anti-VEGF injection only was the most cost-effective strategy. Conclusion: In our study, the anti-VEGF injection for PDR was cost-effective from the payer and societal perspectives.

10 August 2020 in Journal of the Korean Medical Association
Verified
Journal Article
Open access
PDF file
MCMiyoung Choi
Miyoung Choi
HSHo Gyun Shin
Ho Gyun Shin
YJYan Jin
Yan Jin
JKJoo Youn Kim
Joo Youn Kim
KHKwang-Hyub Han
Kwang-Hyub Han
Since the confirmation of the first coronavirus disease 2019 (COVID-19) patient on January 20 2020, COVID-19 infection rate ramped up between February and March in South Korea. This study aimed to provide information on the characteristics of the first two months of COVID-19 prevalence in South Korea and attempted to comprehend preliminary evidence from various sources. We used public data available from the Korea Center for Disease Control and Prevention and situation reports from the World Health Organization from February to March 2020. For additional information, health utilization data from the Organization for Economic Co-operation and Development was used for subgroup analysis. A proportion of meta-analysis was performed. We searched literatures from PubMed, KoreaMed, and CNKI (China National Knowledge Infrastructure) for identifying epidemiological characteristics of COVID-19 and treatment strategies. We monitored domestic and global disease control institutions’ recommendations. The search results and reports were updated every two weeks. In South Korea, the ratio of confirmed cases is divided into two groups; before and after the occurrence of a large cluster infection explosion on February 17 2020 from a religious group called the Shincheonji Church. After the global pandemic announcement by World Health Organization on March 11 2020, the fatality rate of COVID-19 seems to be related to the number of beds and general hospitals. From the literature review, we identified a strong reproduction rate, asymptomatic period or infection, rate of exacerbation, and current treatments. The COVID-19 pandemic in South Korea was inevitable, but the early explosion of infection showed the decline curve afforded by the rigorous tracing, widespread testing, and well-organized health care system.

1 January 2022 in SSRN Electronic Journal
Verified
Preprint
Open access
YJYan Jin
Yan Jin
XGXiafei Guan
Xiafei Guan
MLMeilan Lin
Meilan Lin
SLSipei Liu
Sipei Liu
XLXiuqing Li
Xiuqing Li
LWLei Wang
Lei Wang
Background: There is limited information regarding the reference values for cardiopulmonary exercise testing (CPX) variables in elderly Chinese patients with atrial fibrillation (AF) and heart failure (HF).Methods: This single-center retrospective study included 246 patients (male, 64%; age, 70.6 ± 11.5 years) who completed maximal ramp incremental CPX using cycle ergometry at the Rui An Hospital of Traditional Chinese Medicine, China, between August 1, 2018, and December 31, 2021. The patients were classified into three groups based on medical history: patients with (1) only AF (n = 75), (2) HF with sinus rhythm (SR) (n = 72), and (3) HF with AF (n = 99). Stepwise linear regression was used to fit the equations of the key CPX variables.Results: AT was identified in 70 (93%), 59 (82%), and 80 (81%) patients with AF, HF with SR, and HF with AF, respectively, with no significant difference. The proportion of patients with RER > 1 was 85–89% in each group. Peak oxygen consumption (VO 2 ), carbon dioxide production, ventilation/minute, work rate, and VO 2 at AT were regressed on age, weight, and sex. These predictive equations showed good sample predictive accuracy.Conclusions: The results revealed that the reason for decreased exercise ability among Chinese patients with HF and AF is low skeletal muscle mass rather than a decrease in cardiopulmonary function. The reference values and predictive equations for CPX variables provide a framework for interpreting the response to maximal ramp incremental cycle ergometry among elderly Chinese patients with AF and HF.